AKT1 and idiopathic pulmonary fibrosis: The key node targets that included many more edges, possibly have critical roles in the JBOL treatment of IPF, including MAPK1 (ERK2), MAPK14 (p38), MAPK8 (JNK1), JUN, IL-6, IL-4, and AKT.